insights_auto
Outlook: 27.8% bullish·33.3% bearish
Go to analysischevron_right
NVS:NYSE
Novartis AG
$159.13
arrow_downward
-0.66%(-1.06) 1D
$158.28
arrow_downward
-0.53% (-0.85)todayPre-market
Closed: Nov 17, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 4 analysts giving stock ratings to NVS in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for NVS in the last 3 months.
Highest
Current $159.13
$180.00 (+13.12%)
Average
$159.67 (+0.34%)
Lowest
$136.00 (-14.54%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Thibault Boutherin Morgan Stanley | Buy | Maintained | $163.00 | +2.4% | 10/28/2026 |
Sachin Jain Bank of America Securities | Buy | Maintained | - | - | 10/27/2026 |
Rajesh Kumar HSBC | Hold | Upgraded | $136.00 | -14.5% | 09/10/2026 |
Steve Scala TD Cowen | Hold | Maintained | $180.00 | +13.1% | 09/08/2026 |
Kerry Holford Berenberg Bank | Hold | Maintained | $147.00 | -7.6% | 07/27/2026 |
Jasper Hellweg Argus Research | Buy | Maintained | $170.00 | +6.8% | 07/24/2026 |
Unknown Analyst Goldman Sachs | Sell | Maintained | $139.00 | -12.7% | 07/22/2026 |
Justin Smith Bernstein | Hold | Initiated | - | - | 03/19/2026 |
David Toung Argus Research | Buy | Upgraded | $180.00 | +13.1% | 03/11/2026 |